Showing results (221-230 of 261) with videos related to
Sort By:
Pageof 27
Respiratory Investigation|September 17, 2025
Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendationsMeinoshin Okumura, Kiminori Fujimoto, Nobuharu Hanaoka, et al.Cancer Medicine|August 20, 2020
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinomaYusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, et al.Structure (London, England : 1993)|September 10, 2010
Structural insight into the zinc finger CW domain as a histone modification readerFahu He, Takashi Umehara, Kohei Saito, et al.The Journal of Biological Chemistry|April 6, 2013
Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43)Akemi Shodai, Toshifumi Morimura, Akemi Ido, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsFyza Y Shaikh, James R White, Joell J Gills, et al.European Journal of Clinical Pharmacology|January 18, 2022
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitantHideyuki Hibino, Naomi Sakiyama, Yoshinori Makino, et al.Cancer Science|October 26, 2022
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapyShoko Noda-Narita, Tomoyuki Naito, Hibiki Udagawa, et al.Lung Cancer (Amsterdam, Netherlands)|September 5, 2020
Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapyYusuke Okuma, Ryo Ko, Takehito Shukuya, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.Translational Lung Cancer Research|September 27, 2019
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patientsAkihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, et al.Pageof 27